|Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis|
FM Brennan, A Jackson, D Chantry, R Maini, M Feldmann
The Lancet 334 (8657), 244-247, 1989
|BCG immunotherapy of bladder cancer: 20 years on|
AB Alexandroff, AM Jackson, MA O'Donnell, K James
The Lancet 353 (9165), 1689-1694, 1999
|IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines|
XW Zhu, LA Mulcahy, RAA Mohammed, AHS Lee, HA Franks, L Kilpatrick, ...
Breast Cancer Research 10 (6), R95, 2008
|Changes in urinary cytokines and soluble intercellular adhesion molecule‐1 (ICAM‐1) in bladder cancer patients after Bacillus Calmette—Guérin (BCG) immunotherapy|
AM Jackson, AB Alexandroff, RW Kelly, A Skibinska, K Esuvaranathan, ...
Clinical & Experimental Immunology 99 (3), 369-375, 1995
|Cytokine production in culture by cells isolated from the synovial membrane|
FM Brennan, D Chantry, AM Jackson, RN Mainif, M Feldmann
T–Cell Activation in Health and Disease, 177-186, 1989
|Role for CD40–CD40 ligand interactions in the immune response to solid tumours|
AB Alexandroff, AM Jackson, T Paterson, JL Haley, JA Ross, DL Longo, ...
Molecular immunology 37 (9), 515-526, 2000
|Expression of Interleukin-18, a Th1 Cytokine, in Human Gastric Mucosa Is Increased in Helicobacter pylori Infection|
T Tomita, AM Jackson, N Hida, M Hayat, MF Dixon, T Shimoyama, ...
The Journal of infectious diseases 183 (4), 620-627, 2001
|T cells expressing γδ chain receptors in rheumatoid arthritis|
FM Brennan, M Londei, AM Jackson, T Hercend, MB Brenner, RN Maini, ...
Journal of autoimmunity 1 (4), 319-326, 1988
|Mechanisms of action of intravesical bacille Calmette-Guerin: local immune mechanisms|
S Prescott, AM Jackson, SJ Hawkyard, AB Alexandroff, K James
Clinical infectious diseases 31 (Supplement_3), S91-S93, 2000
|Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy|
K Esuvaranathan, AB Alexandroff, M McIntyre, AM Jackson, S Prescott, ...
The Journal of urology 154 (2), 572-575, 1995
|Recent advances in bacillus Calmette–Guerin immunotherapy in bladder cancer|
AB Alexandroff, S Nicholson, PM Patel, AM Jackson
Immunotherapy 2 (4), 551-560, 2010
|A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy|
KJ Radford, DE Higgins, S Pasquini, EJ Cheadle, L Carta, AM Jackson, ...
Gene therapy 9 (21), 1455, 2002
|Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: statistically weighted syndromes analysis|
AM Jackson, AV Ivshina, O Senko, A Kuznetsova, A Sundan, ...
The Journal of urology 159 (3), 1054-1063, 1998
|Cytokine‐modified Mycobacterium smegmatis as a novel anticancer immunotherapy|
SL Young, M Murphy, XW Zhu, P Harnden, MA O'Donnell, K James, ...
International journal of cancer 112 (4), 653-660, 2004
|Induction of ICAM 1 expression on bladder tumours by BCG immunotherapy.|
AM Jackson, AB Alexandroff, M McIntyre, K Esuvaranathan, K James, ...
Journal of clinical pathology 47 (4), 309-312, 1994
|Bugs as drugs for cancer|
EJ Cheadle, AM Jackson
Immunology 107 (1), 10, 2002
|Human dendritic cells genetically engineered to express a melanoma polyepitope DNA vaccine induce multiple cytotoxic T-cell responses|
SG Smith, PM Patel, J Porte, PJ Selby, AM Jackson
Clinical cancer research 7 (12), 4253-4261, 2001
|The inhibitory effects of interferon gamma on the growth of bladder cancer cells|
SJ Hawkyard, AM Jackson, K James, S Prescott, JF Smyth, GD Chisholm
The Journal of urology 147 (5), 1399-1403, 1992
|The Effects of Recombinant Human Intereron-Gamma on a Panel of Human Bladder Cancer Cell Lines|
S Hawkyard, K James, S Prescott, AM Jackson, AWS Ritchie, JF Smyth, ...
The Journal of urology 145 (5), 1078-1081, 1991
|Bacillus-calmette-guerin (bcg) organisms directly alter the growth of bladder-tumor cells|
AM JACKSON, AB ALEXANDROFF, D FLEMING, S PRESCOTT, ...
International journal of oncology 5 (3), 697-703, 1994